SIGMA logo

Summit for Innovation in Glaucoma Management in Asia

January 9–11, 2026 | Hong Kong
Account
Cart

No products in the cart.

Preliminary Program

  • Registration/Badge collecting
  • Special Feature Talk
  • Welcome Reception

Session 1: The Cutting Edge – Surgical Innovations In Glaucoma
  • 2.1 The Latest MIGS Targeting the Meshwork (iStent, Hydrus)
  • 2.2 Expanding and Opening the Canal (GATT, OMNI, iTrack,
    Tanito hook, KDB, etc)
  • 2.3 New and Improved Tubes and Trabs
  • 2.4 Minimally Invasive Bleb Surgeries (PreserFlo, XEN, etc) – Better than Trab?
  • 2.5 In Development: Future MIGS in the Pipeline
  • 2.6 Suprachoroidal Shunts (iSTAR MINIject, AlloFlo, Ciliatech)
  • 2.7 Panel + Q&A
Session 2: New Medications and Those on the Horizon
  • 2.8 Omidenepag – PGA efficacy without the cosmetic/orbital
    effects?
  • 2.9 Rhopressa – Targeting the Disease Site in Glaucoma?
  • 2.10 Episcleral Venous Pressure – Relieving the Pressure Downstream (or Dropping the Floor on IOP)
  • 2.11 Coming Soon – The New Pharma Targets
  • 2.12 Panel + Q&A
Session 3: Advances in Laser Technology for Glaucoma
  • 2.13 DSLT – Is It a Real Game Changer in the Clinic?
  • 2.14 Micropulse Transcleral Laser – A Gentler CPC?
  • 2.15 Perspectives on When and Where Laser Applies to Angle
    Closure?
  • 2.16 The Future of Lasers in Glaucoma
  • 2.17 Panel + Q&A
Session 4: Diagnostics
  • 2.18 Enhanced Glaucoma Detection with Cutting Edge OCT Analysis
  • 2.19 High Resolution ASOCT and Anterior Segment Imaging
  • 2.20 The Most Advanced VF Algorithms
  • 2.21 Virtual VFs and New Goggles
  • 2.22 Artificial Intelligence in Detecting and Tracking Glaucoma
  • 2.23 Do we need home IOP monitoring in glaucoma care?
  • 2.23 Panel + Q&A

Session 5: Beyond IOP – How Can We Provide Help to the Optic Nerve
  • 3.1 Neuroprotection – Real Talk about Where We Are
  • 3.2 Pie in the Sky – Very Novel Approaches to Protecting Our Nerve
  • 3.3 Stem Cells for Glaucoma – How Can We Get Through the Roadblocks?
  • 3.4 Alternative Approaches to Fixing the IOP and Nerve
  • 3.5 Nicotinamide – What Form and How Much
  • 3.6 Electrify the Optic Nerve?
  • 3.7 How to Design Neuroprotection Trials?
  • 3.8 Panel + Q&A
Session 6: Fresh from the Industry
  • (Talks to be announced)

To top